Alvotech (ALVO) Shares Outstanding (Diluted Average) (2023 - 2024)
Alvotech (ALVO) reported Shares Outstanding (Diluted Average) of $610.0 for Q2 2024, up 56.41% on a YoY basis from $390.0 in Q3 2023, and up 56.41% quarter-over-quarter from $390.0 in Q2 2023.
Alvotech (ALVO) Shares Outstanding (Diluted Average) (2023 - 2024) Analysis & Trends
Alvotech has reported Shares Outstanding (Diluted Average) for 2 years, with the latest figure at $610.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 103.40 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 101.11 Mn |
| 10 | Alvotech | 12.24 Mn | -160.12 Mn | -22.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 610.00 |
| Jun 30, 2023 | 390.00 |